197 related articles for article (PubMed ID: 16405937)
1. Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum.
Vissers JL; Mersch ME; Rosmalen CF; van Heumen MJ; van Geel WJ; Lamers KJ; Rosmalen FM; Swinkels LM; Thomsen J; Herrmann M
Clin Chim Acta; 2006 Apr; 366(1-2):336-40. PubMed ID: 16405937
[TBL] [Abstract][Full Text] [Related]
2. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.
Nylén K; Ost M; Csajbok LZ; Nilsson I; Blennow K; Nellgård B; Rosengren L
J Neurol Sci; 2006 Jan; 240(1-2):85-91. PubMed ID: 16266720
[TBL] [Abstract][Full Text] [Related]
3. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke.
Dvorak F; Haberer I; Sitzer M; Foerch C
Cerebrovasc Dis; 2009; 27(1):37-41. PubMed ID: 19018136
[TBL] [Abstract][Full Text] [Related]
6. Neurological injury markers in children with septic shock.
Hsu AA; Fenton K; Weinstein S; Carpenter J; Dalton H; Bell MJ
Pediatr Crit Care Med; 2008 May; 9(3):245-51. PubMed ID: 18446104
[TBL] [Abstract][Full Text] [Related]
7. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study.
Vos PE; Jacobs B; Andriessen TM; Lamers KJ; Borm GF; Beems T; Edwards M; Rosmalen CF; Vissers JL
Neurology; 2010 Nov; 75(20):1786-93. PubMed ID: 21079180
[TBL] [Abstract][Full Text] [Related]
8. GFAP and S100B in the acute phase of mild traumatic brain injury.
Metting Z; Wilczak N; Rodiger LA; Schaaf JM; van der Naalt J
Neurology; 2012 May; 78(18):1428-33. PubMed ID: 22517109
[TBL] [Abstract][Full Text] [Related]
9. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of glial fibrillary acidic protein during traumatic brain injury in children.
Zurek J; Fedora M
J Trauma; 2011 Oct; 71(4):854-9. PubMed ID: 21986734
[TBL] [Abstract][Full Text] [Related]
11. Urinary S100B concentrations are increased after brain injury in children: A preliminary study.
Berger RP; Kochanek PM
Pediatr Crit Care Med; 2006 Nov; 7(6):557-61. PubMed ID: 17006387
[TBL] [Abstract][Full Text] [Related]
12. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
[TBL] [Abstract][Full Text] [Related]
13. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.
Wiesmann M; Steinmeier E; Magerkurth O; Linn J; Gottmann D; Missler U
Acta Neurol Scand; 2010 Mar; 121(3):178-85. PubMed ID: 19804476
[TBL] [Abstract][Full Text] [Related]
14. [Can serum protein S100beta predict neurological deterioration after moderate or minor traumatic brain injury?].
Bouzat P; Francony G; Declety P; Brun J; Kaddour A; Renversez JC; Jacquot C; Payen JF
Ann Fr Anesth Reanim; 2009 Feb; 28(2):135-9. PubMed ID: 19211218
[TBL] [Abstract][Full Text] [Related]
15. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke.
Wunderlich MT; Wallesch CW; Goertler M
J Neurol Sci; 2004 Dec; 227(1):49-53. PubMed ID: 15546591
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome.
Fujii C; Tokuda T; Ishigami N; Mizuno T; Nakagawa M
Neurosci Lett; 2011 Apr; 494(1):86-8. PubMed ID: 21371524
[TBL] [Abstract][Full Text] [Related]
17. Glial fibrillary acidic protein: a marker of axonal Guillain-Barrè syndrome and outcome.
Notturno F; Caporale CM; De Lauretis A; Uncini A
Muscle Nerve; 2008 Jul; 38(1):899-903. PubMed ID: 18508349
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of serum S100B protein in critically ill patients without brain injury.
Routsi C; Stamataki E; Nanas S; Psachoulia C; Stathopoulos A; Koroneos A; Zervou M; Jullien G; Roussos C
Shock; 2006 Jul; 26(1):20-4. PubMed ID: 16783193
[TBL] [Abstract][Full Text] [Related]
19. An ELISA for glial fibrillary acidic protein.
Petzold A; Keir G; Green AJ; Giovannoni G; Thompson EJ
J Immunol Methods; 2004 Apr; 287(1-2):169-77. PubMed ID: 15099765
[TBL] [Abstract][Full Text] [Related]
20. Measurement of glial fibrillary acidic protein in blood: an analytical method.
van Geel WJ; de Reus HP; Nijzing H; Verbeek MM; Vos PE; Lamers KJ
Clin Chim Acta; 2002 Dec; 326(1-2):151-4. PubMed ID: 12417106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
